Pediatric Aerosol Therapy

References

1. 1.↵
   National Asthma Education and Prevention Program. National Heart, Lung, and Blood Institute, National Institutes of Health. Expert panel report 3: guidelines for the diagnosis and management of asthma. NIH publication No 08-4051, Bethesda, MD: National Institutes of Health; 2007. http://www.nhlbi.nih.gov/health-pro/guidelines/current/asthma-guidelines. Accessed March 10, 2017.
2. 2.
   1. Abadesso C,
   2. Nunes P,
   3. Silvestre C,
   4. Matias E,
   5. Loureiro H,
   6. Almeida H

   . Non-invasive ventilation in acute respiratory failure in children. Pediatr Rep 2012;4(2):e16.

   OpenUrlPubMed
3. 3.
   1. ten Brink F,
   2. Duke T,
   3. Evans J

   . High-flow nasal prong oxygen therapy or nasopharyngeal continuous positive airway pressure for children with moderate-to-severe respiratory distress? Pediatr Crit Care Med 2013;14(7):e326–e331.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Willis LD,
   2. Berlinski A

   . Survey of aerosol delivery techniques to spontaneously breathing tracheostomized children. Respir Care 2012;57(8):1234–1241.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. DiBlasi RM

   . Clinical controversies in aerosol therapy for infants and children. Respir Care 2015;60(6):894–914; discussion 914-916.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. 't Jong GW,
   2. Eland IA,
   3. Sturkenboom MCJM,
   4. van den Anker JN,
   5. Stricker BHC

   . Unlicensed and off-label prescription of respiratory drugs to children. Eur Respir J 2004;23(2):310–313.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Amirav I,
   2. Newhouse MT,
   3. Minocchieri S,
   4. Castro-Rodriguez JA,
   5. Schüepp KG

   . Factors that affect the efficacy of inhaled corticosteroids for infants and young children. J Allergy Clin Immunol 2010;125(6):1206–1211.

   OpenUrlPubMed
8. 8.↵
   1. Hanania NA,
   2. Wittman R,
   3. Kesten S,
   4. Chapman KR

   . Medical personnel's knowledge of and ability to use inhaling devices: metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994;105(1):111–116.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Giner J,
   2. Roura P,
   3. Hernández C,
   4. Torrejón M,
   5. Peiró M,
   6. Fernández MJ,
   7. et al

   . Knowledge and attitudes of nurses in spain about inhaled therapy: results of a national survey. J Aerosol Med Pulm Drug Deliv 2016;29(1):86–93. doi: 10.1089/jamp.2014.1198.

   OpenUrl
10. 10.↵
    1. Castro-Rodriguez JA,
    2. Rodrigo GJ

    . Beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr 2004;145(2):172–177.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Cates CJ,
    2. Welsh EJ,
    3. Rowe BH

    . Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2013;(9):CD000052.
12. 12.↵
    1. Salyer JW,
    2. DiBlasi RM,
    3. Crotwell DN,
    4. Cowan CA,
    5. Carter ER

    . The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. Respir Care 2008;53(3):338–345.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    ProAirR HFA Package Insert. Highlights of prescribing information. Horsham, Pennsylvania: Teva Respiratory; Revised June 2016.
14. 14.
    ProventilR HFA Package Insert. Prescribing information. Kenilworth, New Jersey: Schering-Plough Corporation; Revised December 2014.
15. 15.↵
    VentolinR HFA Package Insert. Highlights of prescribing information. Brentford, United Kingdom: GlaxoSmithKline; Revised December 2014.
16. 16.↵
    1. Berlinski A,
    2. Pennington D

    . Effect of interval between actuations of albuterol HFA inhalers on their aerosol characteristics (abstract). Eur Respir J 2016;48(Suppl 60):A3363.

    OpenUrl
17. 17.↵
    1. Chua HL,
    2. Collis GG,
    3. Newbury AM,
    4. Chan K,
    5. Bower GD,
    6. Sly PD,
    7. Le Souef PN

    . The influence of age on aerosol deposition in children with cystic fibrosis. Eur Respir J 1994;7(12):2185–2191.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Amirav I,
    2. Luder A,
    3. Chleechel A,
    4. Newhouse MT,
    5. Gorenberg M

    . Lung aerosol deposition in suckling infants. Arch Dis Child 2012;97(6):497–501.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Mallol J,
    2. Rattray S,
    3. Walker G,
    4. Cook D,
    5. Robertson CF

    . Aerosol deposition in infants with cystic fibrosis. Pediatr Pulmonol 1996;21(5):276–281.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Schüepp KG,
    2. Devadson S,
    3. Roller C,
    4. Wildhaber JH

    . A complementary combination of delivery device and drug formulation for inhalation therapy in preschool children. Swiss Med Wkly 2004;134(13-14):198–200.

    OpenUrlPubMed
21. 21.↵
    1. Amirav I,
    2. Borojeni AA,
    3. Halamish A,
    4. Newhouse MT,
    5. Golshahi L

    . Nasal versus oral aerosol delivery to the “lungs” in infants and toddlers. Pediatr Pulmonol 2015;50(3):276–283. doi: 10.1002/ppul.22999.

    OpenUrl
22. 22.↵
    1. Xi J,
    2. Si X,
    3. Kim JW,
    4. Berlinski A

    . Simulation of airflow and aerosol deposition in the nasal cavity of a 5-year-old child. J Aerosol Sci 2011;42(3):156–173.

    OpenUrl
23. 23.↵
    1. El Taoum KK,
    2. Xi J,
    3. Kim J,
    4. Berlinski A

    . In-vitro evaluation of nebulized aerosols delivered via nasal route. Respir Care 2015;60(7):1015–1025.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Berlinski A,
    2. Xi J

    . Characterization of nebulized aerosols using a next generation impactor and an anatomically correct pediatric airway model. Respir Drug Deliv 2014;3:637–640.

    OpenUrl
25. 25.↵
    1. Berlinski A,
    2. Hayden JB

    . Optimization of a procedure used to measure aerosol characteristics of nebulized solutions using a cooled next generation impactor. J Aerosol Med Pulm Drug Deliv 2010;23(6):397–404.

    OpenUrlPubMed
26. 26.↵
    1. Cooper B,
    2. Berlinski A

    . Albuterol delivery via facial and tracheostomy route in a model of a spontaneously breathing child. Respir Care 2015;60(12):1749–1758.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Janssens HM,
    2. de Jongste JC,
    3. Fokkens WJ,
    4. Robben SG,
    5. Wouters K,
    6. Tiddens HA

    . The Sophia Anatomical Infant Nose-Throat (Saint) model: a valuable tool to study aerosol deposition in infants. J Aerosol Med 2001;14(4):433–441.

    OpenUrlPubMed
28. 28.↵
    1. Janssens HM,
    2. De Jongste JC,
    3. Hop WC,
    4. Tiddens HA

    . Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model. Chest 2003;123(6):2083–2088.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Bhashyam AR,
    2. Wolf MT,
    3. Marcinkowski AL,
    4. Saville A,
    5. Thomas K,
    6. Carcillo JA,
    7. Corcoran TE

    . Aerosol delivery through nasal cannulas: an in vitro study. J Aerosol Med Pulm Drug Deliv 2008;21(2):181–188.

    OpenUrlPubMed
30. 30.↵
    1. Longest PW,
    2. Golshahi L,
    3. Hindle M

    . Improving pharmaceutical aerosol delivery during noninvasive ventilation: effects of streamlined components. Ann Biomed Eng 2013;41(6):1217–1232.

    OpenUrlPubMed
31. 31.↵
    1. Ari A,
    2. Harwood R,
    3. Sheard M,
    4. Dailey P,
    5. Fink JB

    . In vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatr Pulmonol 2011;46(8):795–801.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Perry SA,
    2. Kesser KC,
    3. Geller DE,
    4. Selhorst DM,
    5. Rendle JK,
    6. Hertzog JH

    . Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system. Pediatr Crit Care Med 2013;14(5):e250–e256.

    OpenUrlPubMed
33. 33.↵
    1. Réminiac F,
    2. Vecellio L,
    3. Heuzé-Vourc'h N,
    4. Petitcollin A,
    5. Respaud R,
    6. Cabrera M,
    7. et al

    . Aerosol therapy in adults receiving high flow nasal cannula oxygen therapy. J Aerosol Med Pulm Drug Deliv 2016;29(2):134–141.

    OpenUrl
34. 34.↵
    1. Réminiac F,
    2. Vecellio L,
    3. Loughlin RM,
    4. Le Pennec D,
    5. Cabrera M,
    6. Vourc'h NH,
    7. et al

    . Nasal high flow nebulization in infants and toddlers: An in vitro and in vivo scintigraphic study. Pediatr Pulmonol 2017;52(3):337–344.

    OpenUrl
35. 35.↵
    1. O'Brien KC,
    2. Newth CJL,
    3. Leung K,
    4. Coates A

    . Epinephrine delivery using a humidified high flow oxygen delivery system (abstract). Am J Respir Crit Care Med 2007;175:A195.

    OpenUrl
36. 36.↵
    1. Leung K,
    2. Newth CJ,
    3. Hotz JC,
    4. O'Brien KC,
    5. Fink JB,
    6. Coates AL

    . Delivery of epinephrine in the vapor phase for the treatment of croup. Pediatr Crit Care Med 2016;17(4):e177–e181.

    OpenUrl
37. 37.↵
    1. Farney KD,
    2. Kuehne BT,
    3. Gibson LA,
    4. Nelin LD,
    5. Shepherd EG

    . In vitro evaluation of radio-labeled aerosol delivery via a variable-flow infant CPAP system. Respir Care 2014;59(3):340–344.

    OpenUrlAbstract/FREE Full Text
38. 38.↵
    1. Boucher P,
    2. Boucher R,
    3. Button BM,
    4. Johnson MR,
    5. Fink JB,
    6. Hickey AJ,
    7. et al

    . Aerosol delivery systems, compositions and methods. United States Patent 20140109899 A1. http://www.google.com/patents/US20140109899. Accessed March 10, 2017.
39. 39.↵
    1. Morgan SE,
    2. Mosakowski S,
    3. Solano P,
    4. Hall JB,
    5. Tung A

    . High-flow nasal cannula and aerosolized β agonists for rescue therapy in children with bronchiolitis: a case series. Respir Care 2015;60(9):e161–e165.

    OpenUrlAbstract/FREE Full Text
40. 40.↵
    1. Longest PW,
    2. Golshahi L,
    3. Behara SR,
    4. Tian G,
    5. Farkas DR,
    6. Hindle M

    . Efficient nose-to-lung (N2L) aerosol delivery with a dry powder inhaler. J Aerosol Med Pulm Drug Deliv 2015;28(3):189–201.

    OpenUrl
41. 41.↵
    1. Golshahi L,
    2. Tian G,
    3. Azimi M,
    4. Son YJ,
    5. Walenga R,
    6. Longest PW,
    7. Hindle M

    . The use of condensational growth methods for efficient drug delivery to the lungs during noninvasive ventilation high flow therapy. Pharm Res 2013;30(11):2917–2930.

    OpenUrlPubMed
42. 42.↵
    1. Trachsel D,
    2. Hammer J

    . Indications for tracheostomy in children. Paediatr Respir Rev 2006;7(3):162–168.

    OpenUrlCrossRefPubMed
43. 43.↵
    1. Baran D,
    2. Dachy A,
    3. Klastersky J

    . Concentration of gentamicin in bronchial secretions of children with cystic fibrosis of tracheostomy (Comparison between the intramuscular route, the endotracheal instillation and aerosolization). Int J Clin Pharmacol Biopharm 1975;12(3):336–341.

    OpenUrlPubMed
44. 44.↵
    1. Lewis JF,
    2. McCaig L

    . Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury. Am Rev Respir Dis 1993;148(5):1187–1193.

    OpenUrlPubMedWeb of Science
45. 45.↵
    1. Berlinski A,
    2. Chavez A

    . Albuterol delivery via metered dose inhaler in a spontaneously breathing pediatric tracheostomy model. Pediatr Pulmonol 2013;48(10):1026–1034.

    OpenUrlPubMed
46. 46.↵
    1. Berlinski A

    . Nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy. Respir Care 2013;58(12):2076–2086.

    OpenUrlAbstract/FREE Full Text
47. 47.↵
    1. Alhamad BR,
    2. Fink JB,
    3. Harwood RJ,
    4. Sheard MM,
    5. Ari A

    . Effect of aerosol devices and administration techniques on drug delivery in a simulated spontaneously breathing pediatric tracheostomy model. Respir Care 2015;60(7):1026–1032.

    OpenUrlAbstract/FREE Full Text
48. 48.↵
    1. Berlinski A,
    2. Cooper B

    . Oronasal and tracheostomy delivery of soft mist and pressurized metered-dose inhalers with valved holding chamber. Respir Care 2016;61(7):913–919.

    OpenUrlAbstract/FREE Full Text
49. 49.↵
    1. Piccuito CM,
    2. Hess DR

    . Albuterol delivery via tracheostomy tube. Respir Care 2005;50(8):1071–1076.

    OpenUrlAbstract/FREE Full Text
50. 50.↵
    1. Amirav I,
    2. Newhouse MT

    . Aerosol therapy in tracheotomized children: time for guidelines! Respir Care 2012;57(8):1350.

    OpenUrlFREE Full Text
51. 51.↵
    1. Sherman JM,
    2. Davis S,
    3. Albamonte-Petrick S,
    4. Chatburn RL,
    5. Fitton C,
    6. Green C,
    7. et al

    . Care of the child with a chronic tracheostomy. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161(1):297–308.

    OpenUrlCrossRefPubMedWeb of Science
52. 52.↵
    1. Ari A,
    2. Harwood RJ,
    3. Sheard MM,
    4. Fink JB

    . An in vitro evaluation of aerosol delivery through tracheostomy and endotracheal tubes using different interfaces. Respir Care 2012;57(7):1066–1070.

    OpenUrlAbstract/FREE Full Text
53. 53.↵
    1. Lazner MR,
    2. Basu AP,
    3. Klonin H

    . Non-invasive ventilation for severe bronchiolitis: analysis and evidence. Pediatr Pulmonol 2012;47(9):909–916.

    OpenUrlCrossRefPubMed
54. 54.↵
    1. Amaddeo A,
    2. Moreau J,
    3. Frapin A,
    4. Khirani S,
    5. Felix O,
    6. Fernandez-Bolanos M,
    7. et al

    . Long term continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV) in children: initiation criteria in real life. Pediatr Pulmonol 2016;51(9):968–974.

    OpenUrl
55. 55.↵
    1. Sterni LM,
    2. Carroll JL

    1. Berlinski A

    . Inhaled drug delivery for children on long-term mechanical ventilation. In: Sterni LM, Carroll JL. Caring for the ventilator dependent child: a clinical guide, 1st edition. New York: Humana Press; 2016:217–239.
56. 56.↵
    1. Brodie T,
    2. Adalat S

    . Unilateral fixed dilated pupil in a well child. Arch Dis Child 2006;91(12):961.

    OpenUrlFREE Full Text
57. 57.↵
    1. Simonds AK,
    2. Hanak A,
    3. Chatwin M,
    4. Morrell M,
    5. Hall A,
    6. Parker KH,
    7. et al

    . Evaluation of droplet dispersion during noninvasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess 2010;14(46):131–172.

    OpenUrlPubMed
58. 58.↵
    1. Fauroux B,
    2. Itti E,
    3. Pigeot J,
    4. Isabey D,
    5. Meignan M,
    6. Ferry G,
    7. et al

    . Optimization of aerosol deposition by pressure support in children with cystic fibrosis: an experimental and clinical study. Am J Respir Crit Care Med 2000;162(6):2265–2271.

    OpenUrlPubMed
59. 59.↵
    1. White CC,
    2. Crotwell DN,
    3. Shen S,
    4. Salyer J,
    5. Yung D,
    6. Zheng J,
    7. DiBlasi RM

    . Bronchodilator delivery during simulated pediatric noninvasive ventilation. Respir Care 2013;58(9):1459–1466.

    OpenUrlAbstract/FREE Full Text
60. 60.↵
    1. Velasco J,
    2. Berlinski A

    . Aerosol delivery in a pediatric model of non-invasive ventilation (abstract). Am J Respir Crit Care Med 2016;A2201.
61. 61.↵
    1. Dai B,
    2. Kang J,
    3. Sun LF,
    4. Tan W,
    5. Zhao HW

    . Influence of exhalation valve and nebulizer position on albuterol delivery during noninvasive positive pressure ventilation. J Aerosol Med Pulm Drug Deliv 2014;27(2):125–132.

    OpenUrlPubMed
62. 62.↵
    1. Branconnier MP,
    2. Hess DR

    . Albuterol delivery during noninvasive ventilation. Respir Care 2005;50(12):1649–1653.

    OpenUrlAbstract/FREE Full Text
63. 63.↵
    1. Lin HL,
    2. Harwood RJ,
    3. Fink JB,
    4. Goodfellow LT,
    5. Ari A

    . In vitro comparison of aerosol delivery using different face masks and flow rates with a high-flow humidity system. Respir Care 2015;60(9):1215–1219.

    OpenUrlAbstract/FREE Full Text
64. 64.↵
    1. Ari A,
    2. Fink JB,
    3. Dhand R

    . Inhalation therapy in patients receiving mechanical ventilation: an update. J Aerosol Med Pulm Drug Deliv 2012;25(6):319–332.

    OpenUrlPubMed
65. 65.↵
    1. Garner SS,
    2. Wiest DB,
    3. Bradley JW,
    4. Habib DM

    . Two administration methods for inhaled salbutamol in intubated patients. Arch Dis Child 2002;87(1):49–53.

    OpenUrlAbstract/FREE Full Text
66. 66.↵
    1. Ferrari F,
    2. Liu ZH,
    3. Lu Q,
    4. Becquemin MH,
    5. Louchahi K,
    6. Aymard G,
    7. et al

    . Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers. Intensive Care Med 2008;34(9):1718–1723.

    OpenUrlCrossRefPubMed
67. 67.↵
    1. Berlinski A,
    2. Holt S,
    3. Thurman T,
    4. Heulitt M

    . Albuterol delivery during mechanical ventilation in an ex-vivo porcine model. J Aerosol Med Pulm Drug Deliv 2013;26(2):A57.

    OpenUrl
68. 68.↵
    1. Garner SS,
    2. Wiest DB,
    3. Bradley JW

    . Albuterol delivery by metered-dose inhaler with a pediatric mechanical ventilatory circuit model. Pharmacotherapy 1994;14(2):210–214.

    OpenUrlPubMed
69. 69.
    1. Wildhaber JH,
    2. Hayden MJ,
    3. Dore ND,
    4. Devadason SG,
    5. LeSouëf PN

    . Salbutamol delivery from a hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits: an in vitro study. Chest 1998;113(1):186–191.

    OpenUrlCrossRefPubMed
70. 70.↵
    1. Berlinski A,
    2. Waldrep JC

    . Metering performance of several metered-dose inhalers with different spacers/holding chambers. J Aerosol Med 2001;14(4):427–432.

    OpenUrlPubMed
71. 71.↵
    1. Diot P,
    2. Morra L,
    3. Smaldone GC

    . Albuterol delivery in a model of mechanical ventilation. Comparison of metered-dose inhaler and nebulizer efficiency. Am J Respir Crit Care Med 1995;152(4 Pt 1):1391–1394.

    OpenUrlCrossRefPubMedWeb of Science
72. 72.↵
    1. Garner SS,
    2. Wiest DB,
    3. Bradley JW

    . Albuterol delivery by metered-dose inhaler in mechanically ventilated pediatric lung model. Crit Care Med 1996;24(5):870–874.

    OpenUrlCrossRefPubMed
73. 73.↵
    1. Habib DM,
    2. Garner SS,
    3. Brandeburg S

    . Effect of helium-oxygen on delivery of albuterol in a pediatric, volume-cycled, ventilated lung model. Pharmacotherapy 1999;19(2):143–149.

    OpenUrlCrossRefPubMedWeb of Science
74. 74.↵
    1. Garner SS,
    2. Wiest DB,
    3. Stevens CE,
    4. Habib DM

    . Effect of heliox on albuterol delivery by metered-dose inhaler in pediatric in vitro models of mechanical ventilation. Pharmacotherapy 2006;26(10):1396–1402.

    OpenUrlPubMed
75. 75.↵
    1. Mitchell JP,
    2. Nagel MW,
    3. Wiersema KJ,
    4. Doyle CC,
    5. Migounov VA

    . The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study. Respir Care 2003;48(11):1025–1032.

    OpenUrlAbstract/FREE Full Text
76. 76.↵
    1. Mouloudi E,
    2. Katsanoulas K,
    3. Anastasaki M,
    4. Askitopoulou E,
    5. Georgopoulos D

    . Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of end-inspiratory pause. Eur Respir J 1998;12(1):165–169.

    OpenUrlAbstract
77. 77.↵
    1. Mouloudi E,
    2. Prinianakis G,
    3. Kondili E,
    4. Georgopoulos D

    . Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern. Eur Respir J 2000;16(2):263–268.

    OpenUrlAbstract/FREE Full Text
78. 78.↵
    1. Hanhan U,
    2. Kissoon N,
    3. Payne M,
    4. Taylor C,
    5. Murphy S,
    6. DeNicola LK

    . Effects of in-line nebulization on preset ventilator variables. Respir Care 1993;38(5):474–478.

    OpenUrl
79. 79.↵
    1. McPeck M,
    2. O'Riordan TG,
    3. Smaldone GC

    . Choice of mechanical ventilator: influence on nebulizer performance. Respir Care 1993;38(8):887–895.

    OpenUrl
80. 80.↵
    1. Ari A,
    2. Areabi H,
    3. Fink JB

    . Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation. Respir Care 2010;55(7):837–844.

    OpenUrlAbstract/FREE Full Text
81. 81.↵
    1. Di Paolo ER,
    2. Pannatier A,
    3. Cotting J

    . In vitro evaluation of bronchodilator drug delivery by jet nebulization during pediatric mechanical ventilation. Pediatr Crit Care Med 2005;6(4):462–469.

    OpenUrlPubMed
82. 82.↵
    1. Ari A,
    2. Atalay OT,
    3. Harwood R,
    4. Sheard MM,
    5. Aljamhan EA,
    6. Fink JB

    . Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation. Respir Care 2010;55(7):845–851.

    OpenUrlAbstract/FREE Full Text
83. 83.↵
    1. Berlinski A,
    2. Willis JR

    . Albuterol delivery via intrapulmonary percussive ventilator and jet nebulizer in a pediatric ventilator model. Respir Care 2010;55(12):1699–1704.

    OpenUrlAbstract/FREE Full Text
84. 84.↵
    1. Berlinski A,
    2. Willis JR

    . Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro model. Respir Care 2013;58(7):1124–1133.

    OpenUrlAbstract/FREE Full Text
85. 85.↵
    1. Sidler-Moix AL,
    2. Dolci U,
    3. Berger-Gryllaki M,
    4. Pannatier A,
    5. Cotting J,
    6. Di Paolo ER

    . Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers. Pediatr Crit Care Med 2013;14(2):e98–e102.

    OpenUrlPubMed
86. 86.↵
    1. Wan GH,
    2. Lin HL,
    3. Fink JB,
    4. Chen YH,
    5. Wang WJ,
    6. Chiu YC,
    7. et al

    . In vitro evaluation of aerosol delivery by different nebulization modes in pediatric and adult mechanical ventilators. Respir Care 2014;59(10):1494–500.

    OpenUrlAbstract/FREE Full Text
87. 87.↵
    1. Berlinski A,
    2. Willis JR

    . Effect of tidal volume and nebulizer type and position on albuterol delivery in a pediatric model of mechanical ventilation. Respir Care 2015;60(10):1424–1430.

    OpenUrlAbstract/FREE Full Text
88. 88.↵
    1. Ahrens RC,
    2. Ries RA,
    3. Popendorf W,
    4. Wiese JA

    . The delivery of therapeutic aerosols through endotracheal tubes. Pediatr Pulmonol 1986;2(1):19–26.

    OpenUrlPubMedWeb of Science
89. 89.↵
    1. Berlinski A,
    2. Kumaran S

    . Particle size characterization of nebulized albuterol delivered by a vibrating mesh nebulizer through pediatric endotracheal tubes (abstract). Am J Respir Crit Care Med 2016;A2191.
90. 90.↵
    1. Fang TP,
    2. Lin HL,
    3. Chiu SH,
    4. Wang SH,
    5. DiBlasi RM,
    6. Tsai YH,
    7. Fink JB

    . Aerosol delivery using jet nebulizer and vibrating mesh nebulizer during high frequency oscillatory ventilation: an in vitro comparison. J Aerosol Med Pulm Drug Deliv 2016;29(5):447–453.

    OpenUrl
91. 91.↵
    1. Longest PW,
    2. Tian G

    . Development of a new technique for the efficient delivery of aerosolized medications to infants on mechanical ventilation. Pharm Res 2015;32(1):321–336.

    OpenUrlPubMed